2011, accessed Aug
Data Availability All data needed to evaluate the conclusions in this study are present in the article and its Supplementary Information
To explore this further, we introduced YK1, a small molecule inhibitor designed to disrupt the ELF3-MED23 interaction, leading to the transcriptional downregulation of HER2 and KRAS
It has not been proven universally more effective than standard reduced glutathione
less Experimental Specifications Techniques Reagents Other Keywords Techniques Reagents Other Keywords Discover related articles Synthesizing Defined Ubiquitin-Modified SUMO Dimers 2025, Springer Protocols Synthesizing Defined Ubiquitin-Modified SUMO Dimers 2025, Springer Protocols Purification of Cytochromes P450: Products of Bacterial Recombinant Expression Systems 1998, Springer Protocols Purification of Cytochromes P450: Products of Bacterial Recombinant Expression Systems 1998, Springer Protocols Synthesizing Defined Ubiquitin-Modified SUMO Dimers 2025, Springer Protocols Synthesizing Defined Ubiquitin-Modified SUMO Dimers 2025, Springer Protocols Purification of Cytochromes P450: Products of Bacterial Recombinant Expression Systems 1998, Springer Protocols Purification of Cytochromes P450: Products of Bacterial Recombinant Expression Systems 1998, Springer Protocols Empty MHC Class I Protein Production 2026, Springer Protocols Empty MHC Class I Protein Production 2026, Springer Protocols Advertisement References Donaldson, J
